Earlier today, I commented on Eli Lilly’s CEO request for greater adoption of HIT and subsequent sharing of aggregate, anonymous patient data to assist in identifying potential adverse drug events (ADE).
Well, low and behold the latest issue of Government Health IT reports that a recent study found current HIPAA rules is making it more cumbersome for researchers to do epidemiological studies.
Looks like it may be a long slog to achieve that Taurel’s vision.
Good luck trying to get noticed for anything other than AI or cybersecurity HIMSS24 was the first HIMSS national conference that I will have missed since I first attended in 2012. It felt weird not to be there with all my friends and colleagues, and I certainly missed...
In this Chilcast episode, John Moore sits down with Deepak Sadagopan, COO of Population Health at Providence and CEO of the Providence Medicare ACO, Health Connect Partners, to discuss the strategic imperatives for healthcare executives navigating the transition to value-based care (VBC).
Workforce / capacity issues and AI – and where the two meet – are still the two biggest topics on clinical executives’ minds right now at both ViVE 2024 and HAS24. Probably the first time I’ve seen the same primary focus two years in a row – historically we’ve always seen a new buzzword / hype topic every year…
0 Comments